Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery Fulltext Access 19 Pages 2006
From counting and pouring to caring: The empathic developmental process of community pharmacists Fulltext Access 19 Pages 2006
Pharmacy Service Orientation: A measure of organizational culture in pharmacy practice sites Fulltext Access 19 Pages 2006
Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders Fulltext Access 19 Pages 2006
Cultural competency: Agenda for Cultural Competency Using Literature and Evidence Fulltext Access 19 Pages 2006
Synthetic high density lipoproteins for the treatment of myocardial ischemia/reperfusion injury Fulltext Access 19 Pages 2006
Relaxin—a pleiotropic hormone and its emerging role for experimental and clinical therapeutics Fulltext Access 19 Pages 2006
Influence of the anabolic-androgenic steroid nandrolone on cannabinoid dependence Fulltext Access 19 Pages 2006
Are hERG channel inhibition and QT interval prolongation all there is in drug-induced torsadogenesis? A review of emerging trends Fulltext Access 19 Pages 2006
Oxidative stress in asthma and COPD: Antioxidants as a therapeutic strategy Fulltext Access 19 Pages 2006
Conformational structure, dynamics, and solvation energies of small alanine peptides in water and carbon tetrachloride Fulltext Access 19 Pages 2006
Gene expression signatures in CD34+-progenitor-derived dendritic cells exposed to the chemical contact allergen nickel sulfate Fulltext Access 19 Pages 2006
Heme as key regulator of major mammalian cellular functions: Molecular, cellular, and pharmacological aspects Fulltext Access 19 Pages 2006
Snake venom metalloproteases — structure and function of catalytic and disintegrin domains Fulltext Access 19 Pages 2006
Marine invertebrate cytochrome P450: Emerging insights from vertebrate and insect analogies Fulltext Access 19 Pages 2006
Intestinal tract injury by drugs: Importance of metabolite delivery by yellow bile road Fulltext Access 19 Pages 2006
The botanical materia medica of the Iatrosophikon—A collection of prescriptions from a monastery in Cyprus Fulltext Access 20 Pages 2006
Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics Fulltext Access 20 Pages 2006
Analgesia and hyperalgesia from CRF receptor modulation in the central nervous system of Fischer and Lewis rats Fulltext Access 20 Pages 2006
Quality of medication information available on retail pharmacy Web sites Fulltext Access 20 Pages 2006
Active dimer of Epratuzumab provides insight into the complex nature of an antibody aggregate Fulltext Access 20 Pages 2006
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions Fulltext Access 20 Pages 2006
A Risk-Based Approach to Establish Stability Testing Conditions for Tropical Countries Fulltext Access 20 Pages 2006
Exploring subjective outcomes perceived by patients receiving a pharmaceutical care service Fulltext Access 20 Pages 2006
Development and validation of a scale to assess attitudes of health care administrators toward the use of e-mail communication between patients and physicians Fulltext Access 21 Pages 2006
Murine models of myocardial and limb ischemia: Diagnostic end-points and relevance to clinical problems Fulltext Access 21 Pages 2006
Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy Fulltext Access 21 Pages 2006
Molecular mechanisms of neuropathic pain–phenotypic switch and initiation mechanisms Fulltext Access 21 Pages 2006
Assessing the proarrhythmic potential of drugs: Current status of models and surrogate parameters of torsades de pointes arrhythmias Fulltext Access 21 Pages 2006
Polynucleotide phosphorylase: An evolutionary conserved gene with an expanding repertoire of functions Fulltext Access 21 Pages 2006
GABAA receptor subtypes as targets for neuropsychiatric drug development Fulltext Access 21 Pages 2006
Testing a pharmacist-patient relationship quality model among older persons with diabetes Fulltext Access 21 Pages 2006
Using the Health Belief Model to test factors affecting patient retention in diabetes-related pharmaceutical care services Fulltext Access 21 Pages 2006
Role and regulation of lung collectins in allergic airway sensitization Fulltext Access 21 Pages 2006
Provision of risk management and risk assessment information: The role of the pharmacist Fulltext Access 21 Pages 2006
β3-Adrenoceptors in the cardiovascular system: Putative roles in human pathologies Fulltext Access 22 Pages 2006
Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms Fulltext Access 22 Pages 2006
Breaking up the tie: Disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion Fulltext Access 22 Pages 2006
The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development Fulltext Access 22 Pages 2006
Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia) Fulltext Access 22 Pages 2006
Drug insurance instability and its correlates: Results from the 2000 Medical Expenditure Panel Survey ∗ Fulltext Access 22 Pages 2006
Use of intravenous immunoglobulin therapy in autoimmune blistering diseases Fulltext Access 22 Pages 2006
Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome Fulltext Access 23 Pages 2006
Update of current therapeutic options for the treatment of postmenopausal osteoporosis Fulltext Access 23 Pages 2006
The importance of circadian rhythms on drug response in hypertension and coronary heart disease—from mice and man Fulltext Access 23 Pages 2006
Hypernociceptive role of cytokines and chemokines: Targets for analgesic drug development? Fulltext Access 23 Pages 2006
Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous system Fulltext Access 23 Pages 2006
Cytochrome P450 4F subfamily: At the crossroads of eicosanoid and drug metabolism Fulltext Access 23 Pages 2006
Cardiovascular endothelins: Essential regulators of cardiovascular homeostasis Fulltext Access 24 Pages 2006
Task analysis of patients' medication-taking practice and the role of making sense: A grounded theory study Fulltext Access 24 Pages 2006
Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies Fulltext Access 24 Pages 2006
Drosophila melanogaster neurobiology, neuropharmacology, and how the fly can inform central nervous system drug discovery Fulltext Access 24 Pages 2006
‘Relaxin’ the stiffened heart and arteries: The therapeutic potential for relaxin in the treatment of cardiovascular disease Fulltext Access 24 Pages 2006
Cytochrome P450 enzymes: Central players in cardiovascular health and disease Fulltext Access 24 Pages 2006
Gene expression profiles of the rat brain both immediately and 3 months following acute sarin exposure Fulltext Access 24 Pages 2006
Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: A review of their discovery, development, and place in therapy Fulltext Access 24 Pages 2006
Inactivating mutations of G protein-coupled receptors and diseases: Structure-function insights and therapeutic implications Fulltext Access 25 Pages 2006
Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids Fulltext Access 25 Pages 2006
Molecular targets of dietary agents for prevention and therapy of cancer Fulltext Access 25 Pages 2006
Non-invasive methods and stimuli for evaluating the skin's microcirculation Fulltext Access 25 Pages 2006
Solifenacin succinate for the treatment of symptoms of overactive bladder Fulltext Access 26 Pages 2006
Interfering with the brain: Use of RNA interference for understanding the pathophysiology of psychiatric and neurological disorders Fulltext Access 26 Pages 2006
CYP17- and CYP11B-dependent steroid hydroxylases as drug development targets Fulltext Access 26 Pages 2006
Eszopiclone, a Nonbenzodiazepine Sedative-Hypnotic Agent for the Treatment of Transient and Chronic Insomnia Fulltext Access 26 Pages 2006
Human ether-a-go-go-related (HERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects Fulltext Access 26 Pages 2006
Patients' evaluation of the appropriateness of their hypertension management—A qualitative study Fulltext Access 26 Pages 2006
Human brain evolution and the “Neuroevolutionary Time-depth Principle:” Implications for the Reclassification of fear-circuitry-related traits in DSM-V and for studying resilience to warzone-related posttraumatic stress disorder Fulltext Access 27 Pages 2006
Basics and Applications of Solid-State Kinetics: A Pharmaceutical Perspective* Fulltext Access 27 Pages 2006
Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: A systematic review of the in vivo proton magnetic resonance spectroscopy findings Fulltext Access 27 Pages 2006
Pharmacological and clinical properties of calcimimetics: Calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism Fulltext Access 27 Pages 2006
The lord of the ring: Mandatory role of the kidney in drug therapy of hypertension Fulltext Access 28 Pages 2006
A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death: Implications for future anti-arrhythmic drug development Fulltext Access 28 Pages 2006
The effect of acute, chronic, and prenatal ethanol exposure on insulin sensitivity Fulltext Access 28 Pages 2006
Involvement of P2 receptors in the growth and survival of neurons in the CNS Fulltext Access 28 Pages 2006
Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance Fulltext Access 29 Pages 2006